Lanean...
Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury
Traumatic brain injury (TBI) in various forms affects millions in the United States annually. There are currently no FDA-approved therapies for acute injury or the chronic comorbidities associated with TBI. Acute phases of TBI are characterized by profound neuroinflammation, a process that stimulate...
Gorde:
| Argitaratua izan da: | Front Behav Neurosci |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985078/ https://ncbi.nlm.nih.gov/pubmed/32038189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2019.00287 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|